nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—MTHFR—atherosclerosis	0.253	0.75	CbGaD
Fluorouracil—ALB—atherosclerosis	0.0847	0.25	CbGaD
Fluorouracil—ABCC3—Ezetimibe—atherosclerosis	0.0847	0.195	CbGbCtD
Fluorouracil—ABCC4—Rosuvastatin—atherosclerosis	0.0647	0.149	CbGbCtD
Fluorouracil—SLC22A7—Pravastatin—atherosclerosis	0.0602	0.139	CbGbCtD
Fluorouracil—ABCG2—Rosuvastatin—atherosclerosis	0.0348	0.0801	CbGbCtD
Fluorouracil—ABCG2—Ezetimibe—atherosclerosis	0.0348	0.0801	CbGbCtD
Fluorouracil—ABCG2—Pravastatin—atherosclerosis	0.0316	0.0729	CbGbCtD
Fluorouracil—ALB—Rosuvastatin—atherosclerosis	0.024	0.0552	CbGbCtD
Fluorouracil—CYP2C8—Simvastatin—atherosclerosis	0.0172	0.0397	CbGbCtD
Fluorouracil—CYP2C8—Pravastatin—atherosclerosis	0.0169	0.0388	CbGbCtD
Fluorouracil—CYP2C8—Lovastatin—atherosclerosis	0.0169	0.0388	CbGbCtD
Fluorouracil—CYP2C9—Rosuvastatin—atherosclerosis	0.0129	0.0298	CbGbCtD
Fluorouracil—CYP2C9—Simvastatin—atherosclerosis	0.012	0.0277	CbGbCtD
Fluorouracil—CYP2C9—Lovastatin—atherosclerosis	0.0118	0.0271	CbGbCtD
Fluorouracil—CYP2C9—Pravastatin—atherosclerosis	0.0118	0.0271	CbGbCtD
Fluorouracil—MTHFR—artery—atherosclerosis	0.00196	0.065	CbGeAlD
Fluorouracil—UPP2—liver—atherosclerosis	0.00183	0.0607	CbGeAlD
Fluorouracil—TYMP—endothelium—atherosclerosis	0.00176	0.0584	CbGeAlD
Fluorouracil—TYMP—blood vessel—atherosclerosis	0.00162	0.0539	CbGeAlD
Fluorouracil—MTHFR—blood vessel—atherosclerosis	0.00153	0.0506	CbGeAlD
Fluorouracil—UMPS—adipose tissue—atherosclerosis	0.00148	0.0491	CbGeAlD
Fluorouracil—UPP1—adipose tissue—atherosclerosis	0.00136	0.045	CbGeAlD
Fluorouracil—DPYD—adipose tissue—atherosclerosis	0.0011	0.0366	CbGeAlD
Fluorouracil—UMPS—liver—atherosclerosis	0.00104	0.0344	CbGeAlD
Fluorouracil—PPAT—adipose tissue—atherosclerosis	0.000955	0.0317	CbGeAlD
Fluorouracil—UPP1—liver—atherosclerosis	0.000953	0.0316	CbGeAlD
Fluorouracil—UMPS—Lovastatin—Pravastatin—atherosclerosis	0.000893	0.22	CbGdCrCtD
Fluorouracil—UMPS—Lovastatin—Simvastatin—atherosclerosis	0.000893	0.22	CbGdCrCtD
Fluorouracil—TYMP—connective tissue—atherosclerosis	0.000833	0.0276	CbGeAlD
Fluorouracil—PPAT—Simvastatin—Lovastatin—atherosclerosis	0.000779	0.192	CbGdCrCtD
Fluorouracil—PPAT—Simvastatin—Pravastatin—atherosclerosis	0.000779	0.192	CbGdCrCtD
Fluorouracil—DPYD—liver—atherosclerosis	0.000774	0.0256	CbGeAlD
Fluorouracil—Inflammation—Ezetimibe—atherosclerosis	0.000761	0.00761	CcSEcCtD
Fluorouracil—Sensory loss—Pravastatin—atherosclerosis	0.000735	0.00735	CcSEcCtD
Fluorouracil—Tenderness—Pravastatin—atherosclerosis	0.00073	0.00729	CcSEcCtD
Fluorouracil—Inflammation—Simvastatin—atherosclerosis	0.000726	0.00726	CcSEcCtD
Fluorouracil—TYMP—cardiovascular system—atherosclerosis	0.000725	0.024	CbGeAlD
Fluorouracil—TYMS—connective tissue—atherosclerosis	0.000715	0.0237	CbGeAlD
Fluorouracil—Amnesia—Rosuvastatin—atherosclerosis	0.000686	0.00686	CcSEcCtD
Fluorouracil—MTHFR—cardiovascular system—atherosclerosis	0.000681	0.0226	CbGeAlD
Fluorouracil—PPAT—liver—atherosclerosis	0.00067	0.0222	CbGeAlD
Fluorouracil—SLC29A1—connective tissue—atherosclerosis	0.000641	0.0212	CbGeAlD
Fluorouracil—Dermatitis contact—Niacin—atherosclerosis	0.000639	0.00639	CcSEcCtD
Fluorouracil—TYMP—adipose tissue—atherosclerosis	0.000639	0.0212	CbGeAlD
Fluorouracil—Photosensitivity—Lovastatin—atherosclerosis	0.000622	0.00622	CcSEcCtD
Fluorouracil—Photosensitivity—Ezetimibe—atherosclerosis	0.000611	0.0061	CcSEcCtD
Fluorouracil—MTHFR—adipose tissue—atherosclerosis	0.000601	0.0199	CbGeAlD
Fluorouracil—Oesophagitis—Niacin—atherosclerosis	0.000591	0.00591	CcSEcCtD
Fluorouracil—Rash maculo-papular—Niacin—atherosclerosis	0.000588	0.00588	CcSEcCtD
Fluorouracil—Photosensitivity—Simvastatin—atherosclerosis	0.000582	0.00582	CcSEcCtD
Fluorouracil—Amnesia—Lovastatin—atherosclerosis	0.000582	0.00582	CcSEcCtD
Fluorouracil—Swelling—Simvastatin—atherosclerosis	0.00058	0.00579	CcSEcCtD
Fluorouracil—Amnesia—Ezetimibe—atherosclerosis	0.000571	0.0057	CcSEcCtD
Fluorouracil—Muscular weakness—Rosuvastatin—atherosclerosis	0.000569	0.00569	CcSEcCtD
Fluorouracil—SLC29A1—cardiovascular system—atherosclerosis	0.000558	0.0185	CbGeAlD
Fluorouracil—TYMS—adipose tissue—atherosclerosis	0.000548	0.0182	CbGeAlD
Fluorouracil—Amnesia—Simvastatin—atherosclerosis	0.000544	0.00544	CcSEcCtD
Fluorouracil—ABCC5—adipose tissue—atherosclerosis	0.000536	0.0178	CbGeAlD
Fluorouracil—Photosensitivity—Pravastatin—atherosclerosis	0.000526	0.00526	CcSEcCtD
Fluorouracil—Amnesia—Pravastatin—atherosclerosis	0.000492	0.00492	CcSEcCtD
Fluorouracil—SLC29A1—adipose tissue—atherosclerosis	0.000492	0.0163	CbGeAlD
Fluorouracil—Dermatitis bullous—Niacin—atherosclerosis	0.000491	0.00491	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000487	0.00487	CcSEcCtD
Fluorouracil—Urinary tract infection—Rosuvastatin—atherosclerosis	0.000483	0.00483	CcSEcCtD
Fluorouracil—CYP2A6—adipose tissue—atherosclerosis	0.00048	0.0159	CbGeAlD
Fluorouracil—Nasopharyngitis—Ezetimibe—atherosclerosis	0.000479	0.00479	CcSEcCtD
Fluorouracil—Muscular weakness—Ezetimibe—atherosclerosis	0.000473	0.00473	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.000469	0.00469	CcSEcCtD
Fluorouracil—Eosinophilia—Lovastatin—atherosclerosis	0.000468	0.00468	CcSEcCtD
Fluorouracil—Sinusitis—Rosuvastatin—atherosclerosis	0.000466	0.00466	CcSEcCtD
Fluorouracil—Eosinophilia—Ezetimibe—atherosclerosis	0.000459	0.00459	CcSEcCtD
Fluorouracil—Muscular weakness—Simvastatin—atherosclerosis	0.000451	0.00451	CcSEcCtD
Fluorouracil—ABCC3—adipose tissue—atherosclerosis	0.00045	0.0149	CbGeAlD
Fluorouracil—TYMP—liver—atherosclerosis	0.000448	0.0149	CbGeAlD
Fluorouracil—Rhinitis—Rosuvastatin—atherosclerosis	0.000447	0.00447	CcSEcCtD
Fluorouracil—SLC22A7—liver—atherosclerosis	0.000447	0.0148	CbGeAlD
Fluorouracil—Pharyngitis—Rosuvastatin—atherosclerosis	0.000443	0.00443	CcSEcCtD
Fluorouracil—Eosinophilia—Simvastatin—atherosclerosis	0.000438	0.00437	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000431	0.00431	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000431	0.0043	CcSEcCtD
Fluorouracil—Dry skin—Niacin—atherosclerosis	0.00043	0.0043	CcSEcCtD
Fluorouracil—Dry skin—Pravastatin—atherosclerosis	0.000424	0.00423	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000423	0.00423	CcSEcCtD
Fluorouracil—MTHFR—liver—atherosclerosis	0.000421	0.014	CbGeAlD
Fluorouracil—Muscular weakness—Niacin—atherosclerosis	0.000414	0.00414	CcSEcCtD
Fluorouracil—Nasopharyngitis—Pravastatin—atherosclerosis	0.000413	0.00413	CcSEcCtD
Fluorouracil—Infestation NOS—Ezetimibe—atherosclerosis	0.000413	0.00413	CcSEcCtD
Fluorouracil—Infestation—Ezetimibe—atherosclerosis	0.000413	0.00413	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000413	0.00413	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000411	0.0041	CcSEcCtD
Fluorouracil—Urinary tract infection—Lovastatin—atherosclerosis	0.000409	0.00409	CcSEcCtD
Fluorouracil—Muscular weakness—Pravastatin—atherosclerosis	0.000408	0.00407	CcSEcCtD
Fluorouracil—Dysphagia—Niacin—atherosclerosis	0.000406	0.00406	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000405	0.00405	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000403	0.00403	CcSEcCtD
Fluorouracil—Arrhythmia—Rosuvastatin—atherosclerosis	0.000399	0.00398	CcSEcCtD
Fluorouracil—Eosinophilia—Pravastatin—atherosclerosis	0.000396	0.00395	CcSEcCtD
Fluorouracil—Angina pectoris—Niacin—atherosclerosis	0.000395	0.00395	CcSEcCtD
Fluorouracil—Sinusitis—Lovastatin—atherosclerosis	0.000395	0.00395	CcSEcCtD
Fluorouracil—Angina pectoris—Pravastatin—atherosclerosis	0.000389	0.00389	CcSEcCtD
Fluorouracil—Sinusitis—Ezetimibe—atherosclerosis	0.000388	0.00387	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000386	0.00386	CcSEcCtD
Fluorouracil—TYMS—liver—atherosclerosis	0.000385	0.0127	CbGeAlD
Fluorouracil—ABCC5—liver—atherosclerosis	0.000376	0.0125	CbGeAlD
Fluorouracil—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000371	0.00371	CcSEcCtD
Fluorouracil—ABCC4—adipose tissue—atherosclerosis	0.000371	0.0123	CbGeAlD
Fluorouracil—Sinusitis—Simvastatin—atherosclerosis	0.00037	0.00369	CcSEcCtD
Fluorouracil—Pharyngitis—Ezetimibe—atherosclerosis	0.000368	0.00368	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000365	0.00364	CcSEcCtD
Fluorouracil—Stomatitis—Niacin—atherosclerosis	0.000353	0.00352	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000351	0.00351	CcSEcCtD
Fluorouracil—Myocardial infarction—Pravastatin—atherosclerosis	0.000349	0.00349	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000349	0.00349	CcSEcCtD
Fluorouracil—Urinary tract infection—Pravastatin—atherosclerosis	0.000346	0.00346	CcSEcCtD
Fluorouracil—SLC29A1—liver—atherosclerosis	0.000345	0.0114	CbGeAlD
Fluorouracil—CYP2A6—liver—atherosclerosis	0.000337	0.0112	CbGeAlD
Fluorouracil—Sinusitis—Pravastatin—atherosclerosis	0.000334	0.00334	CcSEcCtD
Fluorouracil—Alopecia—Lovastatin—atherosclerosis	0.000334	0.00334	CcSEcCtD
Fluorouracil—Myalgia—Rosuvastatin—atherosclerosis	0.000331	0.00331	CcSEcCtD
Fluorouracil—Alopecia—Ezetimibe—atherosclerosis	0.000328	0.00328	CcSEcCtD
Fluorouracil—Haemoglobin—Niacin—atherosclerosis	0.000326	0.00326	CcSEcCtD
Fluorouracil—Rhinitis—Niacin—atherosclerosis	0.000326	0.00325	CcSEcCtD
Fluorouracil—Haemorrhage—Niacin—atherosclerosis	0.000325	0.00325	CcSEcCtD
Fluorouracil—Hypoaesthesia—Niacin—atherosclerosis	0.000323	0.00323	CcSEcCtD
Fluorouracil—Erythema—Ezetimibe—atherosclerosis	0.000323	0.00323	CcSEcCtD
Fluorouracil—Rhinitis—Pravastatin—atherosclerosis	0.000321	0.0032	CcSEcCtD
Fluorouracil—Confusional state—Rosuvastatin—atherosclerosis	0.00032	0.00319	CcSEcCtD
Fluorouracil—Hypoaesthesia—Pravastatin—atherosclerosis	0.000318	0.00318	CcSEcCtD
Fluorouracil—Pharyngitis—Pravastatin—atherosclerosis	0.000317	0.00317	CcSEcCtD
Fluorouracil—ABCC3—liver—atherosclerosis	0.000315	0.0105	CbGeAlD
Fluorouracil—Infection—Rosuvastatin—atherosclerosis	0.000315	0.00315	CcSEcCtD
Fluorouracil—Alopecia—Simvastatin—atherosclerosis	0.000313	0.00312	CcSEcCtD
Fluorouracil—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000311	0.00311	CcSEcCtD
Fluorouracil—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00031	0.0031	CcSEcCtD
Fluorouracil—Vision blurred—Lovastatin—atherosclerosis	0.00031	0.0031	CcSEcCtD
Fluorouracil—Erythema—Simvastatin—atherosclerosis	0.000308	0.00308	CcSEcCtD
Fluorouracil—Anaemia—Ezetimibe—atherosclerosis	0.000298	0.00298	CcSEcCtD
Fluorouracil—Leukopenia—Lovastatin—atherosclerosis	0.000295	0.00295	CcSEcCtD
Fluorouracil—Vision blurred—Simvastatin—atherosclerosis	0.00029	0.0029	CcSEcCtD
Fluorouracil—Arrhythmia—Niacin—atherosclerosis	0.00029	0.0029	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000289	0.00289	CcSEcCtD
Fluorouracil—Alopecia—Niacin—atherosclerosis	0.000287	0.00287	CcSEcCtD
Fluorouracil—Insomnia—Rosuvastatin—atherosclerosis	0.000287	0.00287	CcSEcCtD
Fluorouracil—Arrhythmia—Pravastatin—atherosclerosis	0.000286	0.00286	CcSEcCtD
Fluorouracil—Paraesthesia—Rosuvastatin—atherosclerosis	0.000285	0.00285	CcSEcCtD
Fluorouracil—Anaemia—Simvastatin—atherosclerosis	0.000285	0.00284	CcSEcCtD
Fluorouracil—Erythema—Niacin—atherosclerosis	0.000283	0.00283	CcSEcCtD
Fluorouracil—Alopecia—Pravastatin—atherosclerosis	0.000283	0.00282	CcSEcCtD
Fluorouracil—Myalgia—Lovastatin—atherosclerosis	0.00028	0.0028	CcSEcCtD
Fluorouracil—Chest pain—Lovastatin—atherosclerosis	0.00028	0.0028	CcSEcCtD
Fluorouracil—Dyspepsia—Rosuvastatin—atherosclerosis	0.000279	0.00279	CcSEcCtD
Fluorouracil—Discomfort—Lovastatin—atherosclerosis	0.000277	0.00277	CcSEcCtD
Fluorouracil—Leukopenia—Simvastatin—atherosclerosis	0.000276	0.00275	CcSEcCtD
Fluorouracil—Myalgia—Ezetimibe—atherosclerosis	0.000275	0.00275	CcSEcCtD
Fluorouracil—Chest pain—Ezetimibe—atherosclerosis	0.000275	0.00275	CcSEcCtD
Fluorouracil—Discomfort—Ezetimibe—atherosclerosis	0.000272	0.00271	CcSEcCtD
Fluorouracil—CYP2C9—cardiovascular system—atherosclerosis	0.000271	0.009	CbGeAlD
Fluorouracil—Pain—Rosuvastatin—atherosclerosis	0.000271	0.00271	CcSEcCtD
Fluorouracil—Confusional state—Lovastatin—atherosclerosis	0.000271	0.00271	CcSEcCtD
Fluorouracil—ALB—liver—atherosclerosis	0.000269	0.00892	CbGeAlD
Fluorouracil—Anaphylactic shock—Lovastatin—atherosclerosis	0.000269	0.00269	CcSEcCtD
Fluorouracil—Infection—Lovastatin—atherosclerosis	0.000267	0.00267	CcSEcCtD
Fluorouracil—Vision blurred—Niacin—atherosclerosis	0.000266	0.00266	CcSEcCtD
Fluorouracil—Confusional state—Ezetimibe—atherosclerosis	0.000266	0.00266	CcSEcCtD
Fluorouracil—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000263	0.00263	CcSEcCtD
Fluorouracil—Thrombocytopenia—Lovastatin—atherosclerosis	0.000263	0.00263	CcSEcCtD
Fluorouracil—Vision blurred—Pravastatin—atherosclerosis	0.000262	0.00262	CcSEcCtD
Fluorouracil—Myalgia—Simvastatin—atherosclerosis	0.000262	0.00262	CcSEcCtD
Fluorouracil—Chest pain—Simvastatin—atherosclerosis	0.000262	0.00262	CcSEcCtD
Fluorouracil—ABCG2—adipose tissue—atherosclerosis	0.000262	0.00869	CbGeAlD
Fluorouracil—Infection—Ezetimibe—atherosclerosis	0.000262	0.00262	CcSEcCtD
Fluorouracil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000261	0.00261	CcSEcCtD
Fluorouracil—ABCC4—liver—atherosclerosis	0.00026	0.00863	CbGeAlD
Fluorouracil—Discomfort—Simvastatin—atherosclerosis	0.000259	0.00259	CcSEcCtD
Fluorouracil—Nervous system disorder—Ezetimibe—atherosclerosis	0.000258	0.00258	CcSEcCtD
Fluorouracil—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000258	0.00258	CcSEcCtD
Fluorouracil—Anaemia—Pravastatin—atherosclerosis	0.000257	0.00257	CcSEcCtD
Fluorouracil—Anorexia—Lovastatin—atherosclerosis	0.000256	0.00256	CcSEcCtD
Fluorouracil—Confusional state—Simvastatin—atherosclerosis	0.000253	0.00253	CcSEcCtD
Fluorouracil—Leukopenia—Niacin—atherosclerosis	0.000253	0.00253	CcSEcCtD
Fluorouracil—Urticaria—Rosuvastatin—atherosclerosis	0.000252	0.00252	CcSEcCtD
Fluorouracil—Anaphylactic shock—Simvastatin—atherosclerosis	0.000251	0.00251	CcSEcCtD
Fluorouracil—Oedema—Simvastatin—atherosclerosis	0.000251	0.00251	CcSEcCtD
Fluorouracil—Infection—Simvastatin—atherosclerosis	0.00025	0.0025	CcSEcCtD
Fluorouracil—Leukopenia—Pravastatin—atherosclerosis	0.000249	0.00249	CcSEcCtD
Fluorouracil—Thrombocytopenia—Simvastatin—atherosclerosis	0.000246	0.00246	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000245	0.00245	CcSEcCtD
Fluorouracil—Insomnia—Lovastatin—atherosclerosis	0.000243	0.00243	CcSEcCtD
Fluorouracil—Paraesthesia—Lovastatin—atherosclerosis	0.000241	0.00241	CcSEcCtD
Fluorouracil—Myalgia—Niacin—atherosclerosis	0.000241	0.00241	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00024	0.0024	CcSEcCtD
Fluorouracil—Anorexia—Simvastatin—atherosclerosis	0.00024	0.00239	CcSEcCtD
Fluorouracil—Dyspnoea—Lovastatin—atherosclerosis	0.00024	0.00239	CcSEcCtD
Fluorouracil—Insomnia—Ezetimibe—atherosclerosis	0.000238	0.00238	CcSEcCtD
Fluorouracil—Myalgia—Pravastatin—atherosclerosis	0.000237	0.00237	CcSEcCtD
Fluorouracil—Chest pain—Pravastatin—atherosclerosis	0.000237	0.00237	CcSEcCtD
Fluorouracil—Paraesthesia—Ezetimibe—atherosclerosis	0.000237	0.00236	CcSEcCtD
Fluorouracil—Dyspepsia—Lovastatin—atherosclerosis	0.000236	0.00236	CcSEcCtD
Fluorouracil—Dyspnoea—Ezetimibe—atherosclerosis	0.000235	0.00235	CcSEcCtD
Fluorouracil—Discomfort—Pravastatin—atherosclerosis	0.000234	0.00234	CcSEcCtD
Fluorouracil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000234	0.00233	CcSEcCtD
Fluorouracil—Decreased appetite—Lovastatin—atherosclerosis	0.000234	0.00233	CcSEcCtD
Fluorouracil—Dyspepsia—Ezetimibe—atherosclerosis	0.000232	0.00232	CcSEcCtD
Fluorouracil—Anaphylactic shock—Niacin—atherosclerosis	0.000231	0.00231	CcSEcCtD
Fluorouracil—Oedema—Niacin—atherosclerosis	0.000231	0.00231	CcSEcCtD
Fluorouracil—Pain—Lovastatin—atherosclerosis	0.00023	0.0023	CcSEcCtD
Fluorouracil—Confusional state—Pravastatin—atherosclerosis	0.000229	0.00229	CcSEcCtD
Fluorouracil—Decreased appetite—Ezetimibe—atherosclerosis	0.000229	0.00229	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000229	0.00229	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000227	0.00227	CcSEcCtD
Fluorouracil—Insomnia—Simvastatin—atherosclerosis	0.000227	0.00227	CcSEcCtD
Fluorouracil—Anaphylactic shock—Pravastatin—atherosclerosis	0.000227	0.00227	CcSEcCtD
Fluorouracil—Oedema—Pravastatin—atherosclerosis	0.000227	0.00227	CcSEcCtD
Fluorouracil—Infection—Pravastatin—atherosclerosis	0.000226	0.00226	CcSEcCtD
Fluorouracil—Paraesthesia—Simvastatin—atherosclerosis	0.000226	0.00226	CcSEcCtD
Fluorouracil—Pain—Ezetimibe—atherosclerosis	0.000225	0.00225	CcSEcCtD
Fluorouracil—Tachycardia—Niacin—atherosclerosis	0.000225	0.00225	CcSEcCtD
Fluorouracil—Pruritus—Rosuvastatin—atherosclerosis	0.000224	0.00224	CcSEcCtD
Fluorouracil—Dyspnoea—Simvastatin—atherosclerosis	0.000224	0.00224	CcSEcCtD
Fluorouracil—Thrombocytopenia—Pravastatin—atherosclerosis	0.000222	0.00222	CcSEcCtD
Fluorouracil—Feeling abnormal—Lovastatin—atherosclerosis	0.000221	0.00221	CcSEcCtD
Fluorouracil—Dyspepsia—Simvastatin—atherosclerosis	0.000221	0.00221	CcSEcCtD
Fluorouracil—Anorexia—Niacin—atherosclerosis	0.00022	0.0022	CcSEcCtD
Fluorouracil—Decreased appetite—Simvastatin—atherosclerosis	0.000218	0.00218	CcSEcCtD
Fluorouracil—Feeling abnormal—Ezetimibe—atherosclerosis	0.000217	0.00217	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000217	0.00217	CcSEcCtD
Fluorouracil—Diarrhoea—Rosuvastatin—atherosclerosis	0.000217	0.00217	CcSEcCtD
Fluorouracil—Anorexia—Pravastatin—atherosclerosis	0.000217	0.00216	CcSEcCtD
Fluorouracil—Hypotension—Niacin—atherosclerosis	0.000216	0.00216	CcSEcCtD
Fluorouracil—Pain—Simvastatin—atherosclerosis	0.000215	0.00215	CcSEcCtD
Fluorouracil—Urticaria—Lovastatin—atherosclerosis	0.000213	0.00213	CcSEcCtD
Fluorouracil—Body temperature increased—Lovastatin—atherosclerosis	0.000212	0.00212	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00021	0.0021	CcSEcCtD
Fluorouracil—Dizziness—Rosuvastatin—atherosclerosis	0.00021	0.0021	CcSEcCtD
Fluorouracil—Urticaria—Ezetimibe—atherosclerosis	0.000209	0.00209	CcSEcCtD
Fluorouracil—Insomnia—Niacin—atherosclerosis	0.000209	0.00209	CcSEcCtD
Fluorouracil—Body temperature increased—Ezetimibe—atherosclerosis	0.000208	0.00208	CcSEcCtD
Fluorouracil—Paraesthesia—Niacin—atherosclerosis	0.000207	0.00207	CcSEcCtD
Fluorouracil—Feeling abnormal—Simvastatin—atherosclerosis	0.000207	0.00207	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000207	0.00207	CcSEcCtD
Fluorouracil—Dyspnoea—Niacin—atherosclerosis	0.000206	0.00206	CcSEcCtD
Fluorouracil—Insomnia—Pravastatin—atherosclerosis	0.000205	0.00205	CcSEcCtD
Fluorouracil—Somnolence—Niacin—atherosclerosis	0.000205	0.00205	CcSEcCtD
Fluorouracil—Paraesthesia—Pravastatin—atherosclerosis	0.000204	0.00204	CcSEcCtD
Fluorouracil—Dyspepsia—Niacin—atherosclerosis	0.000203	0.00203	CcSEcCtD
Fluorouracil—Dyspnoea—Pravastatin—atherosclerosis	0.000203	0.00202	CcSEcCtD
Fluorouracil—Decreased appetite—Niacin—atherosclerosis	0.000201	0.002	CcSEcCtD
Fluorouracil—Dyspepsia—Pravastatin—atherosclerosis	0.0002	0.002	CcSEcCtD
Fluorouracil—Rash—Rosuvastatin—atherosclerosis	0.0002	0.002	CcSEcCtD
Fluorouracil—Dermatitis—Rosuvastatin—atherosclerosis	0.0002	0.002	CcSEcCtD
Fluorouracil—Urticaria—Simvastatin—atherosclerosis	0.0002	0.002	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Niacin—atherosclerosis	0.000199	0.00199	CcSEcCtD
Fluorouracil—Body temperature increased—Simvastatin—atherosclerosis	0.000199	0.00199	CcSEcCtD
Fluorouracil—Headache—Rosuvastatin—atherosclerosis	0.000199	0.00199	CcSEcCtD
Fluorouracil—Hypersensitivity—Lovastatin—atherosclerosis	0.000198	0.00198	CcSEcCtD
Fluorouracil—Decreased appetite—Pravastatin—atherosclerosis	0.000197	0.00197	CcSEcCtD
Fluorouracil—Pain—Niacin—atherosclerosis	0.000197	0.00197	CcSEcCtD
Fluorouracil—Pain—Pravastatin—atherosclerosis	0.000194	0.00194	CcSEcCtD
Fluorouracil—Hypersensitivity—Ezetimibe—atherosclerosis	0.000194	0.00194	CcSEcCtD
Fluorouracil—TYMS—Fluvastatin—Rosuvastatin—atherosclerosis	0.000192	0.0472	CbGdCrCtD
Fluorouracil—Pruritus—Lovastatin—atherosclerosis	0.00019	0.0019	CcSEcCtD
Fluorouracil—CYP2C8—liver—atherosclerosis	0.000189	0.00627	CbGeAlD
Fluorouracil—Nausea—Rosuvastatin—atherosclerosis	0.000188	0.00188	CcSEcCtD
Fluorouracil—Feeling abnormal—Pravastatin—atherosclerosis	0.000187	0.00187	CcSEcCtD
Fluorouracil—Pruritus—Ezetimibe—atherosclerosis	0.000186	0.00186	CcSEcCtD
Fluorouracil—Hypersensitivity—Simvastatin—atherosclerosis	0.000185	0.00185	CcSEcCtD
Fluorouracil—Diarrhoea—Lovastatin—atherosclerosis	0.000184	0.00184	CcSEcCtD
Fluorouracil—ABCG2—liver—atherosclerosis	0.000184	0.00609	CbGeAlD
Fluorouracil—Urticaria—Niacin—atherosclerosis	0.000183	0.00183	CcSEcCtD
Fluorouracil—TYMS—Simvastatin—Lovastatin—atherosclerosis	0.000183	0.0451	CbGdCrCtD
Fluorouracil—TYMS—Simvastatin—Pravastatin—atherosclerosis	0.000183	0.0451	CbGdCrCtD
Fluorouracil—Body temperature increased—Niacin—atherosclerosis	0.000182	0.00182	CcSEcCtD
Fluorouracil—Urticaria—Pravastatin—atherosclerosis	0.00018	0.0018	CcSEcCtD
Fluorouracil—Diarrhoea—Ezetimibe—atherosclerosis	0.00018	0.0018	CcSEcCtD
Fluorouracil—Body temperature increased—Pravastatin—atherosclerosis	0.00018	0.0018	CcSEcCtD
Fluorouracil—Pruritus—Simvastatin—atherosclerosis	0.000178	0.00178	CcSEcCtD
Fluorouracil—Dizziness—Lovastatin—atherosclerosis	0.000178	0.00178	CcSEcCtD
Fluorouracil—CYP1A2—liver—atherosclerosis	0.000177	0.00586	CbGeAlD
Fluorouracil—Dizziness—Ezetimibe—atherosclerosis	0.000174	0.00174	CcSEcCtD
Fluorouracil—Diarrhoea—Simvastatin—atherosclerosis	0.000172	0.00172	CcSEcCtD
Fluorouracil—Vomiting—Lovastatin—atherosclerosis	0.000171	0.00171	CcSEcCtD
Fluorouracil—Hypersensitivity—Niacin—atherosclerosis	0.00017	0.0017	CcSEcCtD
Fluorouracil—Rash—Lovastatin—atherosclerosis	0.000169	0.00169	CcSEcCtD
Fluorouracil—Dermatitis—Lovastatin—atherosclerosis	0.000169	0.00169	CcSEcCtD
Fluorouracil—Headache—Lovastatin—atherosclerosis	0.000168	0.00168	CcSEcCtD
Fluorouracil—CYP2C9—liver—atherosclerosis	0.000168	0.00557	CbGeAlD
Fluorouracil—Vomiting—Ezetimibe—atherosclerosis	0.000168	0.00167	CcSEcCtD
Fluorouracil—Hypersensitivity—Pravastatin—atherosclerosis	0.000167	0.00167	CcSEcCtD
Fluorouracil—Dizziness—Simvastatin—atherosclerosis	0.000166	0.00166	CcSEcCtD
Fluorouracil—Rash—Ezetimibe—atherosclerosis	0.000166	0.00166	CcSEcCtD
Fluorouracil—Dermatitis—Ezetimibe—atherosclerosis	0.000166	0.00166	CcSEcCtD
Fluorouracil—Headache—Ezetimibe—atherosclerosis	0.000165	0.00165	CcSEcCtD
Fluorouracil—Pruritus—Niacin—atherosclerosis	0.000163	0.00163	CcSEcCtD
Fluorouracil—Pruritus—Pravastatin—atherosclerosis	0.000161	0.00161	CcSEcCtD
Fluorouracil—Vomiting—Simvastatin—atherosclerosis	0.00016	0.0016	CcSEcCtD
Fluorouracil—Nausea—Lovastatin—atherosclerosis	0.00016	0.0016	CcSEcCtD
Fluorouracil—Rash—Simvastatin—atherosclerosis	0.000158	0.00158	CcSEcCtD
Fluorouracil—Dermatitis—Simvastatin—atherosclerosis	0.000158	0.00158	CcSEcCtD
Fluorouracil—Diarrhoea—Niacin—atherosclerosis	0.000158	0.00158	CcSEcCtD
Fluorouracil—Headache—Simvastatin—atherosclerosis	0.000157	0.00157	CcSEcCtD
Fluorouracil—Nausea—Ezetimibe—atherosclerosis	0.000157	0.00156	CcSEcCtD
Fluorouracil—TYMS—Pitavastatin—Rosuvastatin—atherosclerosis	0.000156	0.0385	CbGdCrCtD
Fluorouracil—Diarrhoea—Pravastatin—atherosclerosis	0.000155	0.00155	CcSEcCtD
Fluorouracil—Dizziness—Niacin—atherosclerosis	0.000153	0.00153	CcSEcCtD
Fluorouracil—Dizziness—Pravastatin—atherosclerosis	0.00015	0.0015	CcSEcCtD
Fluorouracil—Nausea—Simvastatin—atherosclerosis	0.000149	0.00149	CcSEcCtD
Fluorouracil—Vomiting—Niacin—atherosclerosis	0.000147	0.00147	CcSEcCtD
Fluorouracil—Rash—Niacin—atherosclerosis	0.000145	0.00145	CcSEcCtD
Fluorouracil—Dermatitis—Niacin—atherosclerosis	0.000145	0.00145	CcSEcCtD
Fluorouracil—Headache—Niacin—atherosclerosis	0.000145	0.00144	CcSEcCtD
Fluorouracil—Vomiting—Pravastatin—atherosclerosis	0.000144	0.00144	CcSEcCtD
Fluorouracil—Rash—Pravastatin—atherosclerosis	0.000143	0.00143	CcSEcCtD
Fluorouracil—Dermatitis—Pravastatin—atherosclerosis	0.000143	0.00143	CcSEcCtD
Fluorouracil—Headache—Pravastatin—atherosclerosis	0.000142	0.00142	CcSEcCtD
Fluorouracil—Nausea—Niacin—atherosclerosis	0.000137	0.00137	CcSEcCtD
Fluorouracil—Nausea—Pravastatin—atherosclerosis	0.000135	0.00135	CcSEcCtD
Fluorouracil—CYP1A2—Metabolism—ABCG1—atherosclerosis	6.63e-06	7.1e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PLA2G1B—atherosclerosis	6.63e-06	7.1e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.6e-06	7.06e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	6.57e-06	7.04e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.56e-06	7.02e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ABCA1—atherosclerosis	6.54e-06	7e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.53e-06	7e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MAPK3—atherosclerosis	6.52e-06	6.98e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.52e-06	6.98e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP27A1—atherosclerosis	6.5e-06	6.97e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CG—atherosclerosis	6.5e-06	6.96e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.5e-06	6.96e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ALB—atherosclerosis	6.5e-06	6.96e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.48e-06	6.94e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALOX5—atherosclerosis	6.44e-06	6.9e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ALOX5—atherosclerosis	6.41e-06	6.86e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.4e-06	6.86e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTGS2—atherosclerosis	6.38e-06	6.83e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TGFB1—atherosclerosis	6.33e-06	6.78e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.25e-06	6.69e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—LCAT—atherosclerosis	6.24e-06	6.68e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—FABP4—atherosclerosis	6.24e-06	6.68e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—NOS3—atherosclerosis	6.21e-06	6.65e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CG—atherosclerosis	6.19e-06	6.64e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—HMOX1—atherosclerosis	6.17e-06	6.61e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOA2—atherosclerosis	6.17e-06	6.6e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALOX15—atherosclerosis	6.17e-06	6.6e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	6.17e-06	6.6e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	6.17e-06	6.6e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.16e-06	6.6e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOA4—atherosclerosis	6.12e-06	6.56e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCG5—atherosclerosis	6.09e-06	6.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.08e-06	6.52e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP7A1—atherosclerosis	6.01e-06	6.44e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PPARG—atherosclerosis	5.98e-06	6.4e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.95e-06	6.38e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IGF1—atherosclerosis	5.95e-06	6.38e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—STAT3—atherosclerosis	5.94e-06	6.36e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.92e-06	6.34e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—APOB—atherosclerosis	5.91e-06	6.33e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—LPA—atherosclerosis	5.88e-06	6.3e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—INS—atherosclerosis	5.86e-06	6.28e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NAMPT—atherosclerosis	5.78e-06	6.19e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GSTM1—atherosclerosis	5.75e-06	6.16e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NAMPT—atherosclerosis	5.75e-06	6.15e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.74e-06	6.15e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—LIPC—atherosclerosis	5.74e-06	6.15e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	5.73e-06	6.14e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.71e-06	6.12e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—LIPC—atherosclerosis	5.71e-06	6.12e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APOC3—atherosclerosis	5.71e-06	6.11e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—BGN—atherosclerosis	5.7e-06	6.1e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTGS2—atherosclerosis	5.68e-06	6.09e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MAPK3—atherosclerosis	5.68e-06	6.08e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APOC3—atherosclerosis	5.67e-06	6.08e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—LDLR—atherosclerosis	5.67e-06	6.08e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.66e-06	6.06e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SERPINE1—atherosclerosis	5.65e-06	6.05e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—LPL—atherosclerosis	5.65e-06	6.05e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOA5—atherosclerosis	5.64e-06	6.04e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—LDLR—atherosclerosis	5.64e-06	6.04e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—HMOX1—atherosclerosis	5.61e-06	6.01e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—atherosclerosis	5.58e-06	5.98e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP27A1—atherosclerosis	5.56e-06	5.95e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CETP—atherosclerosis	5.54e-06	5.93e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GPX1—atherosclerosis	5.51e-06	5.9e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CETP—atherosclerosis	5.51e-06	5.9e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TGFB1—atherosclerosis	5.51e-06	5.9e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—atherosclerosis	5.48e-06	5.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.48e-06	5.87e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5.47e-06	5.86e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	5.43e-06	5.81e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NOS3—atherosclerosis	5.4e-06	5.78e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ALB—atherosclerosis	5.38e-06	5.76e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—APOB—atherosclerosis	5.37e-06	5.75e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.37e-06	5.75e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CD36—atherosclerosis	5.36e-06	5.75e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.34e-06	5.72e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.32e-06	5.7e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.31e-06	5.68e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SCARB1—atherosclerosis	5.31e-06	5.68e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SCARB1—atherosclerosis	5.27e-06	5.65e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOA2—atherosclerosis	5.27e-06	5.64e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	5.27e-06	5.64e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	5.27e-06	5.64e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALOX15—atherosclerosis	5.27e-06	5.64e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALOX5—atherosclerosis	5.24e-06	5.62e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GSTM1—atherosclerosis	5.23e-06	5.6e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCG5—atherosclerosis	5.2e-06	5.58e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.2e-06	5.57e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.17e-06	5.53e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—NOS3—atherosclerosis	5.14e-06	5.51e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—LPL—atherosclerosis	5.13e-06	5.49e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—MTHFR—atherosclerosis	5.08e-06	5.45e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—LPA—atherosclerosis	5.03e-06	5.38e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HMGCR—atherosclerosis	5.01e-06	5.37e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GPX1—atherosclerosis	5e-06	5.36e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPARA—atherosclerosis	4.99e-06	5.34e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HMGCR—atherosclerosis	4.98e-06	5.34e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CD36—atherosclerosis	4.87e-06	5.22e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—BGN—atherosclerosis	4.87e-06	5.21e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.84e-06	5.19e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.83e-06	5.18e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AGT—atherosclerosis	4.83e-06	5.17e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOA5—atherosclerosis	4.82e-06	5.16e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	4.81e-06	5.15e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—atherosclerosis	4.77e-06	5.11e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—APOE—atherosclerosis	4.73e-06	5.07e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—atherosclerosis	4.7e-06	5.04e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NAMPT—atherosclerosis	4.7e-06	5.04e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CAV1—atherosclerosis	4.69e-06	5.02e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.68e-06	5.01e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—APOA1—atherosclerosis	4.68e-06	5.01e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.68e-06	5.01e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—LIPC—atherosclerosis	4.67e-06	5.01e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOC3—atherosclerosis	4.64e-06	4.97e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	4.64e-06	4.97e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—MTHFR—atherosclerosis	4.62e-06	4.95e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—LDLR—atherosclerosis	4.62e-06	4.94e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.59e-06	4.91e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.54e-06	4.87e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.53e-06	4.86e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PPARA—atherosclerosis	4.53e-06	4.85e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.52e-06	4.84e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CETP—atherosclerosis	4.51e-06	4.83e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.49e-06	4.81e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALOX5—atherosclerosis	4.48e-06	4.8e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ABCA1—atherosclerosis	4.47e-06	4.78e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ABCA1—atherosclerosis	4.44e-06	4.76e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—atherosclerosis	4.4e-06	4.71e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AGT—atherosclerosis	4.39e-06	4.7e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SCARB1—atherosclerosis	4.32e-06	4.62e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—APOE—atherosclerosis	4.3e-06	4.61e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CG—atherosclerosis	4.27e-06	4.58e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CAV1—atherosclerosis	4.26e-06	4.56e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—APOA1—atherosclerosis	4.25e-06	4.55e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.2e-06	4.5e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—atherosclerosis	4.15e-06	4.45e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.14e-06	4.43e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPARG—atherosclerosis	4.12e-06	4.42e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HMGCR—atherosclerosis	4.08e-06	4.37e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—INS—atherosclerosis	4.04e-06	4.33e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NAMPT—atherosclerosis	4.02e-06	4.3e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4e-06	4.28e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—LIPC—atherosclerosis	3.99e-06	4.28e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOC3—atherosclerosis	3.97e-06	4.25e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—LDLR—atherosclerosis	3.94e-06	4.23e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—atherosclerosis	3.89e-06	4.16e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CG—atherosclerosis	3.88e-06	4.16e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CETP—atherosclerosis	3.85e-06	4.13e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HMOX1—atherosclerosis	3.83e-06	4.1e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—atherosclerosis	3.83e-06	4.1e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HMOX1—atherosclerosis	3.81e-06	4.08e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PPARG—atherosclerosis	3.75e-06	4.01e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ALB—atherosclerosis	3.71e-06	3.97e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SCARB1—atherosclerosis	3.69e-06	3.95e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—atherosclerosis	3.68e-06	3.95e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.68e-06	3.94e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—MAPK3—atherosclerosis	3.68e-06	3.94e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—INS—atherosclerosis	3.67e-06	3.93e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APOB—atherosclerosis	3.67e-06	3.93e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APOB—atherosclerosis	3.65e-06	3.91e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCA1—atherosclerosis	3.63e-06	3.89e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.59e-06	3.85e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTM1—atherosclerosis	3.57e-06	3.82e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—atherosclerosis	3.57e-06	3.82e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTM1—atherosclerosis	3.55e-06	3.8e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—NOS3—atherosclerosis	3.55e-06	3.8e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—LPL—atherosclerosis	3.5e-06	3.75e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HMGCR—atherosclerosis	3.48e-06	3.73e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—LPL—atherosclerosis	3.48e-06	3.73e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GPX1—atherosclerosis	3.42e-06	3.66e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GPX1—atherosclerosis	3.4e-06	3.64e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ALB—atherosclerosis	3.37e-06	3.61e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CD36—atherosclerosis	3.33e-06	3.57e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CD36—atherosclerosis	3.31e-06	3.55e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—atherosclerosis	3.24e-06	3.47e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—NOS3—atherosclerosis	3.22e-06	3.45e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—atherosclerosis	3.21e-06	3.43e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MTHFR—atherosclerosis	3.15e-06	3.38e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.14e-06	3.37e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MTHFR—atherosclerosis	3.14e-06	3.36e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HMOX1—atherosclerosis	3.12e-06	3.34e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCA1—atherosclerosis	3.11e-06	3.33e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPARA—atherosclerosis	3.1e-06	3.32e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPARA—atherosclerosis	3.08e-06	3.3e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AGT—atherosclerosis	3e-06	3.21e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOB—atherosclerosis	2.99e-06	3.2e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AGT—atherosclerosis	2.98e-06	3.19e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—atherosclerosis	2.95e-06	3.16e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APOE—atherosclerosis	2.94e-06	3.15e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APOE—atherosclerosis	2.92e-06	3.13e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CAV1—atherosclerosis	2.91e-06	3.12e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTM1—atherosclerosis	2.91e-06	3.11e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APOA1—atherosclerosis	2.9e-06	3.11e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CAV1—atherosclerosis	2.89e-06	3.1e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APOA1—atherosclerosis	2.89e-06	3.09e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—atherosclerosis	2.86e-06	3.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—LPL—atherosclerosis	2.85e-06	3.05e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GPX1—atherosclerosis	2.78e-06	2.98e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CD36—atherosclerosis	2.71e-06	2.9e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HMOX1—atherosclerosis	2.66e-06	2.85e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.65e-06	2.84e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CG—atherosclerosis	2.64e-06	2.82e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.57e-06	2.75e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPARG—atherosclerosis	2.56e-06	2.74e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOB—atherosclerosis	2.55e-06	2.73e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPARG—atherosclerosis	2.54e-06	2.72e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPARA—atherosclerosis	2.52e-06	2.7e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—INS—atherosclerosis	2.51e-06	2.69e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—INS—atherosclerosis	2.49e-06	2.67e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.48e-06	2.66e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—atherosclerosis	2.48e-06	2.66e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AGT—atherosclerosis	2.44e-06	2.61e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—LPL—atherosclerosis	2.44e-06	2.61e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOE—atherosclerosis	2.39e-06	2.56e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GPX1—atherosclerosis	2.38e-06	2.55e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CAV1—atherosclerosis	2.37e-06	2.54e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—atherosclerosis	2.36e-06	2.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOA1—atherosclerosis	2.36e-06	2.53e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CD36—atherosclerosis	2.32e-06	2.48e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALB—atherosclerosis	2.3e-06	2.46e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NOS3—atherosclerosis	2.2e-06	2.36e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.19e-06	2.35e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NOS3—atherosclerosis	2.19e-06	2.34e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.16e-06	2.31e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPARA—atherosclerosis	2.15e-06	2.31e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AGT—atherosclerosis	2.08e-06	2.23e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPARG—atherosclerosis	2.08e-06	2.23e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOE—atherosclerosis	2.04e-06	2.19e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—INS—atherosclerosis	2.04e-06	2.19e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CAV1—atherosclerosis	2.02e-06	2.17e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOA1—atherosclerosis	2.02e-06	2.16e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.01e-06	2.16e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—atherosclerosis	2e-06	2.14e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALB—atherosclerosis	1.87e-06	2.01e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.84e-06	1.97e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NOS3—atherosclerosis	1.79e-06	1.92e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPARG—atherosclerosis	1.78e-06	1.91e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—INS—atherosclerosis	1.75e-06	1.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.64e-06	1.75e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—atherosclerosis	1.63e-06	1.75e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALB—atherosclerosis	1.6e-06	1.71e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NOS3—atherosclerosis	1.53e-06	1.64e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—atherosclerosis	1.48e-06	1.59e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.4e-06	1.5e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—atherosclerosis	1.01e-06	1.08e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—atherosclerosis	1.01e-06	1.08e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—atherosclerosis	8.23e-07	8.82e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—atherosclerosis	7.03e-07	7.53e-06	CbGpPWpGaD
